Show me a pre-revenue, small-cap, med-tech stock that isn't bumpy. In any case, Resapp has travelled pretty smoothly these last twelve months. You want bumpy, have a look at PXS, NTI, NSB...
Ann: Clinical Study of COPD Screening in Indigenous Australians, page-75
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)